Latest Insider Transactions at Soleno Therapeutics Inc (SLNO)
This section provides a real-time view of insider transactions for Soleno Therapeutics Inc (SLNO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of SOLENO THERAPEUTICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of SOLENO THERAPEUTICS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 01
2024
|
James H Mackaness CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
8,077
-3.19%
|
$395,773
$49.8 P/Share
|
|
Oct 01
2024
|
Kristen Yen |
SELL
Open market or private sale
|
Direct |
3,108
-1.84%
|
$152,292
$49.8 P/Share
|
|
Oct 01
2024
|
Patricia C Hirano |
SELL
Open market or private sale
|
Direct |
3,108
-1.39%
|
$152,292
$49.8 P/Share
|
|
Oct 01
2024
|
Bhatnagar Anish CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
21,633
-1.46%
|
$1,060,017
$49.8 P/Share
|
|
Aug 29
2024
|
James H Mackaness CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
6,870
-2.58%
|
$322,890
$47.5 P/Share
|
|
Aug 29
2024
|
Kristen Yen |
SELL
Open market or private sale
|
Direct |
5,435
-3.05%
|
$255,445
$47.5 P/Share
|
|
Aug 29
2024
|
Bhatnagar Anish CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
58,391
-3.69%
|
$2,744,377
$47.5 P/Share
|
|
Aug 29
2024
|
Patricia C Hirano |
SELL
Open market or private sale
|
Direct |
5,435
-2.33%
|
$255,445
$47.5 P/Share
|
|
Aug 29
2024
|
Vivo Opportunity, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
100,000
-1.56%
|
$4,700,000
$47.22 P/Share
|
|
Aug 28
2024
|
James H Mackaness CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
6,661
-2.39%
|
$313,067
$47.61 P/Share
|
|
Aug 28
2024
|
Kristen Yen |
SELL
Open market or private sale
|
Direct |
5,270
-2.8%
|
$247,690
$47.61 P/Share
|
|
Aug 28
2024
|
Bhatnagar Anish CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
56,613
-3.36%
|
$2,660,811
$47.61 P/Share
|
|
Aug 28
2024
|
Patricia C Hirano |
SELL
Open market or private sale
|
Direct |
5,270
-2.17%
|
$247,690
$47.61 P/Share
|
|
Aug 28
2024
|
Vivo Opportunity, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
425,000
-6.23%
|
$19,975,000
$47.35 P/Share
|
|
Aug 27
2024
|
Vivo Opportunity, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
500,000
-6.83%
|
$24,000,000
$48.73 P/Share
|
|
Aug 15
2024
|
Dawn Carter Bir |
BUY
Grant, award, or other acquisition
|
Direct |
13,000
+50.0%
|
-
|
|
Aug 06
2024
|
Bhatnagar Anish CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
69,131
-2.54%
|
$3,041,764
$44.93 P/Share
|
|
Aug 06
2024
|
Patricia C Hirano |
SELL
Open market or private sale
|
Direct |
5,977
-1.57%
|
$262,988
$44.93 P/Share
|
|
Aug 06
2024
|
James H Mackaness CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
8,134
-1.85%
|
$357,896
$44.93 P/Share
|
|
Aug 06
2024
|
Kristen Yen |
SELL
Open market or private sale
|
Direct |
5,957
-1.99%
|
$262,108
$44.93 P/Share
|
|
Aug 05
2024
|
Bhatnagar Anish CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
58,213
-3.0%
|
$2,619,585
$45.81 P/Share
|
|
Aug 05
2024
|
Patricia C Hirano |
SELL
Open market or private sale
|
Direct |
5,032
-1.9%
|
$226,440
$45.81 P/Share
|
|
Aug 05
2024
|
James H Mackaness CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
6,849
-2.22%
|
$308,205
$45.81 P/Share
|
|
Aug 05
2024
|
Kristen Yen |
SELL
Open market or private sale
|
Direct |
5,017
-2.39%
|
$225,765
$45.81 P/Share
|
|
Jul 17
2024
|
Meredith Manning Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+50.0%
|
-
|
|
Jul 17
2024
|
Bhatnagar Anish CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
850,000
+46.36%
|
-
|
|
Jul 17
2024
|
James H Mackaness CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+39.1%
|
-
|
|
Jul 17
2024
|
Patricia C Hirano |
BUY
Grant, award, or other acquisition
|
Direct |
85,000
+38.86%
|
-
|
|
Jul 17
2024
|
Kristen Yen |
BUY
Grant, award, or other acquisition
|
Direct |
85,000
+44.44%
|
-
|
|
Jul 17
2024
|
Michael F. Huang Sr. VP of Clinical Development |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+50.0%
|
-
|
|
Jul 01
2024
|
Kristen Yen |
SELL
Open market or private sale
|
Direct |
2,170
-4.71%
|
$88,970
$41.43 P/Share
|
|
Jul 01
2024
|
Bhatnagar Anish CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
19,256
-6.44%
|
$789,496
$41.43 P/Share
|
|
Jul 01
2024
|
Patricia C Hirano |
SELL
Open market or private sale
|
Direct |
2,170
-2.15%
|
$88,970
$41.43 P/Share
|
|
Jul 01
2024
|
James H Mackaness CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,190
-5.82%
|
$294,790
$41.43 P/Share
|
|
Jun 06
2024
|
Matthew Pauls |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+50.0%
|
-
|
|
Jun 06
2024
|
Andrew Sinclair |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+50.0%
|
-
|
|
Jun 06
2024
|
Birgitte Volck |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+32.43%
|
-
|
|
Jun 06
2024
|
William G Harris |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+29.68%
|
-
|
|
Jun 06
2024
|
Ernest Mario |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+3.26%
|
-
|
|
May 21
2024
|
Ernest Mario |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
62,000
+24.94%
|
$248,000
$4.5 P/Share
|
|
Apr 30
2024
|
Vivo Opportunity, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
351,242
-4.58%
|
$15,805,890
$45.13 P/Share
|
|
Apr 29
2024
|
Vivo Opportunity, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
750,000
-8.91%
|
$35,250,000
$47.8 P/Share
|
|
Apr 01
2024
|
Kristen Yen |
SELL
Open market or private sale
|
Direct |
2,218
-4.42%
|
$90,938
$41.39 P/Share
|
|
Apr 01
2024
|
Bhatnagar Anish CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
18,980
-5.68%
|
$778,180
$41.39 P/Share
|
|
Apr 01
2024
|
Patricia C Hirano |
SELL
Open market or private sale
|
Direct |
2,218
-2.4%
|
$90,938
$41.39 P/Share
|
|
Apr 01
2024
|
James H Mackaness CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,175
-3.87%
|
$212,175
$41.39 P/Share
|
|
Jan 25
2024
|
Patricia C Hirano |
SELL
Open market or private sale
|
Direct |
832
-1.89%
|
$39,936
$48.3 P/Share
|
|
Jan 25
2024
|
Kristen Yen |
SELL
Open market or private sale
|
Direct |
397
-1.52%
|
$19,056
$48.3 P/Share
|
|
Jan 25
2024
|
Bhatnagar Anish CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
2,527
-1.45%
|
$121,296
$48.3 P/Share
|
|
Jan 08
2024
|
Ernest Mario |
SELL
Bona fide gift
|
Direct |
3,523
-2.75%
|
-
|